Literature DB >> 1978784

Expression of c-erbB-2 protein product in bladder cancer.

C Wright1, K Mellon, D E Neal, P Johnston, I P Corbett, C H Horne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1978784      PMCID： PMC1971522          DOI： 10.1038/bjc.1990.375

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  17 in total

Review 1.  Molecular biology of urological tumours.

Authors:  P J Russell; J L Brown; S M Grimmond; D Raghavan
Journal:  Br J Urol       Date:  1990-02

2.  Expression of the c-erbB-2 protein in normal and transformed cells.

Authors:  W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

3.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

Authors:  R M Hudziak; J Schlessinger; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.

Authors:  M Tal; M Wetzler; Z Josefberg; A Deutch; M Gutman; D Assaf; R Kris; Y Shiloh; D Givol; J Schlessinger
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

5.  Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

Authors:  C Wright; B Angus; S Nicholson; J R Sainsbury; J Cairns; W J Gullick; P Kelly; A L Harris; C H Horne
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

6.  Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.

Authors:  J Fujita; O Yoshida; Y Yuasa; J S Rhim; M Hatanaka; S A Aaronson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

7.  Oncogenes and bladder cancer.

Authors:  P R Malone; K V Visvanathan; B A Ponder; R J Shearer; I C Summerhayes
Journal:  Br J Urol       Date:  1985-12

8.  Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.

Authors:  J A Drebin; V C Link; R A Weinberg; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

Authors:  W J Muller; E Sinn; P K Pattengale; R Wallace; P Leder
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

10.  Evaluation of epidermal growth factor receptors in bladder tumours.

Authors:  M S Berger; C Greenfield; W J Gullick; J Haley; J Downward; D E Neal; A L Harris; M D Waterfield
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640
View more
  16 in total

1.  Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles.

Authors:  Chunhui Wang; Wenju Wang; Jiansong Wang; Hui Zhan; Lihong Jiang; Ruping Yan; Zongliu Hou; Huirong Zhu; Lirui Yu; Yunqiang Shi; Mingxia Ding; Changxing Ke
Journal:  Tumour Biol       Date:  2013-02-22

2.  A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).

Authors:  M Dror Michaelson; Chen Hu; Huong T Pham; Douglas M Dahl; Chin Lee-Wu; Gregory P Swanson; Jacqueline Vuky; R Jeffrey Lee; Luis Souhami; Brian Chang; Asha George; Howard Sandler; William Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-19       Impact factor: 7.038

3.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

4.  Expression of p53 product in Chinese human bladder carcinoma.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-05

Review 5.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.

Authors:  I Brotherick; B K Shenton; W K Cowan; B Angus; C H Horne; M J Higgs; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

7.  Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-01

8.  Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma.

Authors:  Gonzague de Pinieux; Delphine Colin; Anne Vincent-Salomon; Jérôme Couturier; Delphine Amsellem-Ouazana; Philippe Beuzeboc; Annick Vieillefond
Journal:  Virchows Arch       Date:  2004-03-17       Impact factor: 4.064

9.  Expression of c-erbB-2 protein in papillary thyroid carcinomas.

Authors:  D R Haugen; L A Akslen; J E Varhaug; J R Lillehaug
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

Authors:  A Berner; J M Nesland; H Waehre; J Silde; S D Fosså
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.